Particle.news

Download on the App Store

Dr. Ananda Bandyopadhyay and Prof. Pierre Van Damme Receive Prestigious Global Vaccine Research Award

The 2025 IVI–SK Bioscience Park MahnHoon Award honors their groundbreaking contributions to the development of a novel oral polio vaccine and global health collaboration.

US-based Indian doctor receives global recognition for vaccine research
Image

Overview

  • Dr. Ananda Bandyopadhyay, a US-based physician originally from Kolkata, and Professor Pierre Van Damme of the University of Antwerp were jointly awarded the 2025 IVI–SK Bioscience Park MahnHoon Award.
  • The award recognizes their pioneering work in the development and deployment of a novel oral polio vaccine, a significant advancement in global disease eradication efforts.
  • Dr. Bandyopadhyay has played a key role in India's polio elimination and measles surveillance initiatives, contributing to the country's polio-free status since 2014.
  • The International Vaccine Institute, the only global organization dedicated exclusively to vaccine discovery and delivery for low- and middle-income countries, hosted the award ceremony on April 30, 2025.
  • Speaking from Seattle, Dr. Bandyopadhyay emphasized that the recognition highlights the importance of global partnerships and will inspire future vaccine research.